Insmed Historical Balance Sheet
INSM Stock | USD 71.04 1.87 2.56% |
Trend analysis of Insmed Inc balance sheet accounts such as Total Current Liabilities of 236.9 M or Property Plant And Equipment Net of 109.6 M provides information on Insmed's total assets, liabilities, and equity, which is the actual value of Insmed Inc to its prevalent stockholders. By breaking down trends over time using Insmed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Insmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Insmed Inc is a good buy for the upcoming year.
Insmed Inventory |
|
Insmed |
About Insmed Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Insmed Inc at a specified time, usually calculated after every quarter, six months, or one year. Insmed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Insmed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Insmed currently owns. An asset can also be divided into two categories, current and non-current.
Insmed Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Insmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Insmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Insmed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Insmed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Insmed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At this time, Insmed's Cash is very stable compared to the past year. As of the 7th of September 2024, Non Current Assets Total is likely to grow to about 420.8 M, though Retained Earnings are likely to grow to (3.3 B).
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 89.2M | 131.7M | 215.0M | 225.7M | Total Assets | 1.2B | 1.7B | 1.3B | 1.4B |
Insmed balance sheet Correlations
Click cells to compare fundamentals
Insmed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Insmed balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 742.3M | 796.2M | 1.2B | 1.7B | 1.3B | 1.4B | |
Other Current Liab | 280K | 63.4M | 89.2M | 131.7M | 215.0M | 225.7M | |
Total Current Liabilities | 85.2M | 118.8M | 135.2M | 190.2M | 225.6M | 236.9M | |
Total Stockholder Equity | 261.7M | 275.9M | 410.5M | 88.0M | (331.9M) | (315.3M) | |
Property Plant And Equipment Net | 113.1M | 97.2M | 95.5M | 102.1M | 104.4M | 109.6M | |
Net Debt | (90.4M) | (127.9M) | (104.5M) | 103.8M | 721.6M | 757.7M | |
Retained Earnings | (1.5B) | (1.8B) | (2.3B) | (2.7B) | (3.4B) | (3.3B) | |
Accounts Payable | 13.2M | 42.9M | 35.8M | 50.5M | 65.4M | 68.7M | |
Cash | 487.4M | 532.8M | 716.8M | 1.1B | 482.4M | 506.5M | |
Non Current Assets Total | 187.1M | 173.3M | 406.5M | 383.1M | 400.8M | 420.8M | |
Non Currrent Assets Other | 20.3M | 26.8M | 51.0M | 76.1M | 96.6M | 101.4M | |
Cash And Short Term Investments | 487.4M | 532.8M | 716.8M | 1.1B | 780.4M | 819.5M | |
Common Stock Total Equity | 897K | 1.0M | 1.2M | 1.4M | 1.6M | 804.3K | |
Common Stock Shares Outstanding | 84.6M | 97.6M | 112.1M | 123.0M | 140.4M | 147.5M | |
Liabilities And Stockholders Equity | 742.3M | 796.2M | 1.2B | 1.7B | 1.3B | 1.4B | |
Other Current Assets | 20.2M | 24.0M | 28.9M | 25.5M | 24.2M | 25.4M | |
Other Stockholder Equity | 1.8B | 2.1B | 2.7B | 2.8B | 3.1B | 3.3B | |
Total Liab | 480.6M | 520.3M | 833.0M | 1.6B | 1.7B | 1.7B | |
Property Plant And Equipment Gross | 113.1M | 97.2M | 95.5M | 102.1M | 149.0M | 156.5M | |
Total Current Assets | 555.2M | 622.9M | 837.0M | 1.3B | 929.1M | 975.5M | |
Accumulated Other Comprehensive Income | (10K) | 193K | 968K | 756K | (745K) | (782.3K) | |
Common Stock | 897K | 1.0M | 1.2M | 1.4M | 1.5M | 837.2K | |
Other Assets | 72.5M | 70.0M | 51.0M | 113.7M | 130.7M | 137.3M | |
Good Will | 58.7M | 53.7M | 49.3M | 136.1M | 156.5M | 164.4M | |
Non Current Liabilities Total | 395.4M | 401.5M | 697.9M | 1.4B | 1.4B | 1.5B | |
Intangible Assets | 53.7M | 49.3M | 73.8M | 68.8M | 63.7M | 61.3M | |
Property Plant Equipment | 60.2M | 54.0M | 53.0M | 56.5M | 65.0M | 68.2M | |
Net Receivables | 19.2M | 16.6M | 24.4M | 29.7M | 41.2M | 43.2M | |
Short Long Term Debt Total | 397.0M | 404.8M | 612.3M | 1.2B | 1.2B | 1.3B | |
Long Term Debt | 335.9M | 356.3M | 566.6M | 1.1B | 1.2B | 1.2B | |
Inventory | 28.3M | 49.6M | 67.0M | 69.9M | 83.2M | 87.4M | |
Net Tangible Assets | 208.0M | 226.6M | 200.5M | (116.9M) | (134.5M) | (127.7M) | |
Retained Earnings Total Equity | (1.5B) | (1.8B) | (2.3B) | (2.7B) | (2.4B) | (2.3B) | |
Capital Surpluse | 1.8B | 2.1B | 2.7B | 2.8B | 3.2B | 3.4B | |
Deferred Long Term Liab | 52.1M | 47.3M | 72.0M | 37.6M | 43.2M | 45.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Insmed Stock
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.27) | Revenue Per Share 2.224 | Quarterly Revenue Growth 0.17 | Return On Assets (0.25) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.